| 000 | 02470ngm a2200625 a 4500 | ||
|---|---|---|---|
| 001 | HST5559 | ||
| 003 | UkLoHST | ||
| 006 | m c | ||
| 007 | cr|cna|||a|||| | ||
| 007 | vz|czazum | ||
| 008 | 211204s2021 enk|||||||||||s|||v|eng d | ||
| 028 | 5 | 0 |
_a5559 _bHenry Stewart Talks |
| 035 | _a(UkLoHST)4808 | ||
| 040 |
_aUkLoHST _beng _cUkLoHST |
||
| 100 | 1 |
_aRaviglione, Mario C. _4spk |
|
| 245 | 1 | 4 |
_aThe End TB Strategy _h[electronic resource] : _btowards TB elimination, part 2 / _cMario C. Raviglione. |
| 246 | 3 | _aEnd TB Strategy : towards TB elimination, 2 | |
| 260 |
_aLondon : _bHenry Stewart Talks, _c2021. |
||
| 300 |
_a1 online resource (1 streaming video file (52 min.) : _bcolor, sound). |
||
| 490 | 1 |
_aTuberculosis, _x2056-452X |
|
| 500 | _aAnimated audio-visual presentation with synchronized narration. | ||
| 500 | _aTitle from title frames. | ||
| 505 | 0 | _aContents: Tuberculosis -- The End TB Strategy -- Rapid molecular diagnostic testing -- Drug resistant TB -- Drug susceptibility testing -- TB and HIV -- Latent TB -- BCG vaccination -- Universal health -- TB and COVID-19. | |
| 506 | _aAccess restricted to subscribers. | ||
| 538 | _aMode of access: World Wide Web. | ||
| 610 | 2 | 0 | _aWorld Health Organization. |
| 650 | 0 | _aCOVID-19 (Disease) | |
| 650 | 0 |
_aHIV infections _xPrevention. |
|
| 650 | 0 | _aMultidrug-resistant tuberculosis. | |
| 650 | 0 |
_aTuberculosis _xChemotherapy. |
|
| 650 | 0 |
_aTuberculosis _xDiagnosis. |
|
| 650 | 0 |
_aTuberculosis _xPrevention. |
|
| 650 | 2 | _aAntitubercular Agents. | |
| 650 | 2 | _aBCG Vaccine. | |
| 650 | 2 | _aCoinfection. | |
| 650 | 2 |
_aCommunicable Disease Control _xorganization & administration. |
|
| 650 | 2 | _aCOVID-19. | |
| 650 | 2 | _aDisease Eradication. | |
| 650 | 2 |
_aHIV Infections _xprevention & control. |
|
| 650 | 2 | _aInternational Cooperation. | |
| 650 | 2 | _aLatent Tuberculosis. | |
| 650 | 2 | _aMicrobial Sensitivity Tests. | |
| 650 | 2 | _aMolecular Diagnostic Techniques. | |
| 650 | 2 | _aMycobacterium tuberculosis. | |
| 650 | 2 | _aSARS-CoV-2. | |
| 650 | 2 |
_aTuberculosis _xdiagnosis. |
|
| 650 | 2 |
_aTuberculosis _xdrug therapy. |
|
| 650 | 2 |
_aTuberculosis _xprevention & control. |
|
| 650 | 2 | _aTuberculosis, Multidrug-Resistant. | |
| 650 | 2 | _aVaccination. | |
| 650 | 2 | _aWorld Health. | |
| 830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pTuberculosis. |
|
| 856 | 4 | 0 | _uhttps://hstalks.com/bs/4808/ |
| 856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/686/ _3Series |
| 999 |
_c75628 _d75628 |
||